Recommended Starting Dose for Quillivant in Children
The recommended starting dose of Quillivant XR for children 6 years of age and older is 20 mg once daily in the morning 1.
Key Dosing Parameters
Initial Dosing:
- Start at 20 mg once daily in the morning
- Administer with or without food
- Critical: Vigorously shake the bottle for at least 10 seconds before each dose to ensure proper suspension 1
Titration Schedule:
- Increase weekly in increments of 10-20 mg as needed
- Maximum studied dose: 60 mg daily (doses above this are not recommended) 1
- Continue titration until achieving a well-tolerated, therapeutic response
Important Age Restriction
Quillivant XR is NOT recommended for children younger than 6 years of age 1. This limitation exists because younger children (under 6) demonstrated:
- Higher plasma exposure compared to older children at the same dosage
- Higher incidence of adverse reactions, particularly weight loss
- Different metabolic rates requiring different dosing considerations 1
Clinical Context
This 20 mg starting dose for Quillivant XR differs from traditional immediate-release methylphenidate dosing (which typically starts at 5 mg) 2. Do not substitute Quillivant XR for other methylphenidate products on a milligram-per-milligram basis due to different methylphenidate base compositions and differing pharmacokinetic profiles 1.
The extended-release formulation provides coverage throughout the school day with once-daily dosing, which improves adherence compared to multiple daily doses of immediate-release formulations. In clinical trials, this formulation demonstrated significant efficacy in reducing ADHD symptoms in the laboratory classroom setting 3.
Common Pitfalls to Avoid
- Failing to shake the bottle adequately: The suspension must be vigorously shaken for at least 10 seconds before each dose
- Starting too high in younger children: Always begin at 20 mg regardless of weight
- Switching from other methylphenidate products at equivalent doses: Different formulations have different pharmacokinetics
- Alcohol consumption: Patients should avoid alcohol, as 20% alcohol concentration can increase drug exposure by approximately 20% 1